RxDoctor Payments Data

Jonathan Roberts, MD

Interventional Cardiology · Hollywood, FLNPI 1154385789

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Acist Medical Systems, Inc. at 45.9% of the total. Reporting peaked in 2023 at $2,833 and has fallen 78.7% since, to $603 in 2025. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.

$6,101in general payments, 2019–2025

Across 33 payments — averaging $184.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acist Medical Systems, Inc.$3K
  • Philips North America LLC$2K
  • Edwards Lifesciences$413
  • Abbott$346
  • Boston Scientific$269
  • Cardinal Health 200 LLC$167
  • plus $164 from 4 others
$277,688in research payments, 2019–2025

Across 48 payments — averaging $5785.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Z-medica, LLC$104K
  • Shockwave Medical, Inc$81K
  • Philips North America LLC$50K
  • M.a. Med Alliance S.A.$25K
  • CSL Behring$16K
  • Boston Scientific$2K

What the payments were for

  • Consulting fees$2,80046%
  • Travel & lodging$1,17919%
  • Food & beverage$2,12335%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,101 in reported general payments places this provider in the 40th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$32,424
Medicare patients
75
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate11$73

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Hollywood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →